Excelitas Technologies Acquires Heraeus Noblelight
Excelitas Technologies® Corp., a leading industrial and medical technology manufacturer focused on delivering innovative, market-driven photonic solutions, announces that it has completed the successful acquisition of the Noblelight business from Heraeus Group (Hanau, Germany), including operations in Germany, United Kingdom, United States, China and Japan, along with several key application centers and sales offices around the world.
Noblelight specializes in the development and manufacture of specialty lighting components and system solutions, from ultraviolet to infrared, used within analytical instrumentation, industrial curing, water treatment, electronics manufacturing, medical and cosmetic therapy, battery production and many others.
“We are very pleased that Noblelight and its strong team are now part of Excelitas. The combined knowledge and manufacturing expertise of Excelitas and Noblelight now present one of the broadest and most extensive light technology offerings available from a single source. We share a field-proven go-to-market strategy based upon deep customer engagement, which enables market success and ensures long-standing business relationships,” said Ron Keating, Excelitas Technologies CEO.
The acquisition of Noblelight represents the latest in a series of strategic acquisitions by Excelitas Technologies since its establishment in 2010.
“We are greatly enthused with the possibilities of our new partnership. We see significant opportunities in leveraging our combined capabilities to best serve our customer base and continue an accelerated path for profitable growth,” said Roland Eckl, Managing Director of Noblelight.
The acquisition officially closed on January 1, 2024. Terms of the transaction are not being disclosed.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Ilke Panzer appointed new Greiner Bio-One Division Manager - "We were convinced by her impressive career at major US companies such as General Electric and Johnson & Johnson"

Research combines graphene and painkiller receptor

Molecular machine in nano cage - What a toy: a tiny gyroscope that would fit in a human cell and that can be controlled from the outside

108Labs is building the world’s first cell cultured human milk factory

Was the secret spice in primal gene soup a thickener?

Detection of viruses, bacteria and toxins in real time - IHP scientists win Leibniz Founding Award 2021

Membrane molecule keeps nerve impulses hopping

Detecting the handedness of a single nanoparticle - New microscope-based spectrometer records both polarization states simultaneously and permitted the first observation of a dynamically moving single nanoparticle
